T. Neuhaus, J. Luyken, and S. Stier, “Discontinuation of the Tyrosine Kinase Inhibitor Sunitinib in Patients with Metastatic Renal Cell Carcinoma: A Case Series”, Urol J, vol. 11, no. 2, pp. 1494–1498, May 2014.